News brief
On September 28, 2026, Suzhou-based XinYun Biotech, developer of AI-powered cerebrovascular interventional ultrasound diagnostic systems, raised tens of millions of RMB in an Angel+ round backed by Delian Capital, Zhongguancun Capital and Sanbo Brain Hospital. The company was founded by Zhao Jun.
Connected profiles
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月28日，据公开报道，苏州AI脑血管介入超声诊断系统研发商鑫云生科完成数千万元天使+轮融资，德联资本、中关村资本与三博脑科共同参与。公司由赵军创立，专注脑血管介入超声诊疗领域。